Investment Rating - The report maintains an "Outperform" rating for the food and beverage sector, indicating expected performance above the market index by over 10% [4][5][70]. Core Views - The food and beverage sector is entering a peak stocking season ahead of the Spring Festival, with multiple favorable catalysts for the restaurant supply chain [1]. - The report highlights a divergence in the fundamentals of different categories, with beverages outperforming food and alcoholic beverages [2]. - Key investment themes for 2026 include cost advantages from low raw material prices, efficiency improvements through supply chain optimization, innovation-driven growth, and opportunities for recovery in distressed sectors [3][10]. Summary by Relevant Sections Alcoholic Beverages - The report emphasizes the strong dividend characteristics of the liquor sector, particularly with Moutai's market reforms gradually taking effect. It suggests that high-quality companies with pricing power and regional influence are likely to achieve greater growth [2][10]. - Recommendations include Moutai, Shanxi Fenjiu, and Luzhou Laojiao, with a focus on their growth potential and market positioning [2][10]. Beer - The beer industry is currently managing inventory well and is poised for demand recovery. The report recommends Yanjing Beer for its rapid growth and strong internal reforms [11]. Dairy Products - The dairy sector is experiencing orderly stocking for the Spring Festival, with a recommendation for leading companies like Yili, which is expected to benefit from improved margins and demand recovery [14]. Snacks - The report suggests focusing on strong alpha stocks in the snack sector, particularly those innovating in konjac products. Leading companies like Weidong and Yanjinpuzi are highlighted for their competitive advantages and growth potential [12][17]. Restaurant Supply Chain - The restaurant supply chain is entering a busy stocking season, with clear recovery trends. Recommendations include leading companies in the compound seasoning sector and those with national capacity and channel layouts [13][14]. Beverage Sector - The beverage sector is primarily focused on destocking during the off-season, with stable stocking for the Spring Festival. Leading companies like Nongfu Spring and Dongpeng Beverage are recommended for their aggressive growth strategies [15].

Investment Rating - The report maintains an "Outperform" rating for the consumer-grade 3D printing industry [1] Core Insights - Technological advancements are driving the growth of the consumer-grade 3D printing industry, which is entering a period of widespread adoption. The global market is expected to exceed $4 billion by 2024, with a compound annual growth rate (CAGR) of 28% from 2020 to 2024. The sales of 3D printers alone are projected to reach $2.1 billion, growing at a CAGR of 21% during the same period [3][15] - The consumer-grade 3D printing market is characterized by intense competition, with Chinese companies dominating the landscape. By 2024, China is expected to account for 45% of global 3D printer exports, with major markets in the US and Europe [3][24] - The report highlights the growth potential of 3D printing consumables, which are expected to reach $1 billion by 2024, with a CAGR of 36% from 2024 to 2029. Chinese companies are gradually capturing market share in this segment [3][45] Summary by Sections 1. Technological Advancements Driving Growth - Continuous improvements in hardware and software are lowering the operational barriers for consumer-grade 3D printing, leading to increased market penetration. The global consumer-grade 3D printing market is projected to reach $4 billion by 2024, with a CAGR of 28% from 2020 to 2024 [3][15] - The number of consumer-grade 3D printers is expected to reach approximately 15.8 million units globally by 2024, indicating a penetration rate of only 1.8% among the 860 million households in the US, Europe, and China, suggesting significant growth potential [3][15] 2. Competitive Landscape - The report identifies a competitive landscape where Chinese companies, such as Chuangxiang Sanwei and Tuozhu, are leading the market. Chuangxiang Sanwei holds a market share of 28% in cumulative shipments from 2020 to 2024, while Tuozhu is expected to lead in 2024 with a 29% market share [3][27] - The competition is primarily driven by product capabilities, with a focus on technological research and development, as well as supply chain efficiency [3][28] 3. Company Profiles - Chuangxiang Sanwei offers a diverse range of products, including 3D printers, consumables, and services, with projected revenues of 2.3 billion yuan in 2024 and a stable gross margin of around 30% [3][35] - Tuozhu Technology focuses on integrating advanced technologies into their 3D printers, enhancing user experience and product performance, which has propelled them to the top of the industry [3][44] 4. Growth of 3D Printing Consumables - The consumables segment is expected to grow significantly, with the market projected to reach $1 billion by 2024, driven by the increasing number of 3D printers in use. The CAGR for this segment is anticipated to be 36% from 2024 to 2029 [3][45] - Chinese companies are gradually increasing their market share in the consumables sector, particularly in upstream resin production and modified plastics [3][45]

Core Insights - The report emphasizes the transformative role of Agentic AI in enhancing the asset allocation process through a fully automated "pan-quantitative" strategy development, allowing non-programmers to engage in data collection, signal generation, strategy construction, and backtesting [4][6]. - The introduction of AI-driven Black-Litterman asset allocation strategies has significantly outperformed equal-weight benchmarks, with annualized returns of 18.29% and 20.37% for DeepSeek-V3 and Qwen2.5-72B models, respectively, compared to the benchmark's 11.85% [6][57]. - AI-enhanced risk parity models have shown improved risk control without increasing volatility, achieving an annualized return of 4.71% with a Sharpe ratio increase from 1.39 to 1.46 [6][68]. Group 1: Agentic AI and Quantitative Empowerment - Agentic AI facilitates a complete quantitative strategy development process, enabling researchers and investors to automate the investment research workflow through natural language interactions [4][5]. - The AI-driven process begins with knowledge decomposition and cross-domain mapping, followed by task clarification and execution, resulting in standardized and reproducible quantitative outcomes [5][20]. - The shift from traditional methods to AI tools allows for a more structured approach in investment research, focusing on clear objectives and constraints rather than just prompt engineering [16][20]. Group 2: AI-Driven Black-Litterman Asset Allocation - The Black-Litterman model integrates market equilibrium expectations with investor views, utilizing AI to automatically generate asset perspectives based on macroeconomic data and market trends [52][53]. - The model's performance is significantly enhanced by AI-generated views, with the DeepSeek-V3 and Qwen2.5-72B models achieving annualized returns of 18.29% and 20.37%, respectively, compared to the equal-weight benchmark's 11.85% [55][57]. - The AI-enhanced strategy captures short-term market opportunities effectively, leading to superior risk-adjusted returns and reduced maximum drawdowns [57]. Group 3: AI-Enhanced Risk Parity Models - The risk parity strategy aims to allocate weights such that each asset contributes equally to the portfolio's risk, with AI dynamically determining the covariance estimation window based on market conditions [63][64]. - AI models adaptively select optimal window lengths for risk assessment, enhancing the robustness and interpretability of the portfolio [64][68]. - The Qwen-72B model demonstrated improved monthly win rates and risk-adjusted returns without increasing volatility, outperforming traditional fixed-window strategies [68][69].

Investment Rating - The report maintains an "Outperform" rating for the pharmaceutical and biotechnology sector [5]. Core Insights - The pharmaceutical sector has shown weaker performance compared to the overall market, with the biopharmaceutical sector outperforming with a 7.81% increase [1]. - The brain-computer interface (BCI) industry is experiencing significant breakthroughs and commercialization opportunities, driven by favorable policies and technological advancements [2][18]. - The AI healthcare market is projected to grow substantially, with the global market size expected to increase from USD 13.7 billion in 2022 to USD 155.3 billion by 2030, reflecting a CAGR of 35.5% [23][28]. Summary by Sections Market Performance - The overall A-share market increased by 4.09%, while the biopharmaceutical sector rose by 7.81%, indicating strong sector performance [1]. - The TTM price-to-earnings ratio for the biopharmaceutical sector is at 38.96x, which is at the 85.59th percentile of the past five years [1]. Brain-Computer Interface (BCI) - The BCI market is expected to see explosive growth due to policy support, including the "14th Five-Year Plan" and the establishment of independent billing codes for BCI devices [2][18]. - Key investment opportunities include upstream hardware suppliers, midstream companies with core patents, and downstream firms that create commercial applications in rehabilitation and industrial control [2][18]. AI in Healthcare - AI is identified as a critical application area in healthcare, with various themes such as AI in drug development, multi-omics, precision diagnostics, imaging devices, and smart healthcare being highlighted for investment [3][22]. - The launch of ChatGPTHealth by OpenAI signifies a growing trend in integrating AI with healthcare applications, enhancing patient interaction with health data [29]. Company Earnings Forecasts - Several companies in the sector have been rated as "Outperform," with projected net profits for 2024 ranging from CNY 1.4 billion to CNY 116.7 billion [4]. - Notable companies include Mindray Medical (CNY 116.7 billion), WuXi AppTec (CNY 93.5 billion), and Aier Eye Hospital (CNY 35.6 billion), all showing strong growth potential [4].

证券研究报告 | 2026年01月12日 新澳股份（603889.SH） 羊毛价格上涨叠加运动户外羊毛产品需求扩容，看好公司量价齐升 |  | 公司研究·公司快评 |  | 纺织服饰·纺织制造 |  | 投资评级：优于大市（维持） | | --- | --- | --- | --- | --- | --- | | 证券分析师： | 丁诗洁 | 0755-81981391 | | dingshijie@guosen.com.cn | 执证编码：S0980520040004 | | 证券分析师： | 刘佳琪 | 010-88005446 | liujiaqi@guosen.com.cn | | 执证编码：S0980523070003 | 事项： 羊毛价格持续上涨：2025 年三季度以来羊毛价格持续上涨。三季度同比增长 11.5%，季度累计上涨 22.6%； 10 月上旬价格环比有所下降，而在中下旬重新恢复上涨，10 月底价格环比下降 2.9%，同比上涨 26.8%； 11、12 月价格增速提升，11 月底环比/同比分别上涨 4.8%/32.0%，12 月底环比/同比分别上涨 4.4%/39.9%， 2025 ...

证券研究报告 | 2026年01月12日 美元债双周报（26 年第 2 周） 弱于大市 美国经济数据分化加剧，财政主导风险升温 美国 12 月非农就业增 5 万不及预期，年度增幅创疫情后最弱，就业数据拖 累降息预期。美国 12 月非农就业人数仅增加 5 万人，低于预期的 6.5 万， 且前两个月数据合计下修 7.6 万人，导致全年新增就业仅为 58.4 万人， 创疫情以来最低水平。尽管失业率从 4.5%降至 4.4%，薪资同比增长 3.8%， 但劳动力参与率下降表明就业市场的改善并不稳固。这份疲弱的就业报 告发布后，利率互换市场对美联储 1 月降息的预期几乎完全消失，预计 首次降息将推迟至 6 月，全年降息幅度约为 50 个基点。我们认为失业 率意外下降暂时缓解了劳动力市场的担忧，支持美联储在 1 月会议保持 观望态度。 美国 12 月制造业 PMI 持续萎缩，服务业回暖。12 月美国 ISM 制造业 PMI 跌至 47.9，连续第十个月低于荣枯线 50，显示制造业持续收缩且降幅 为近年来最大。新订单和出口订单持续萎缩，尽管就业指标降幅收窄， 成本压力依旧高企。相比之下，服务业表现强劲，ISM 服务业 PMI ...

证券研究报告 | 2026年01月12日 美元债双周报（26 年第 2 周） 弱于大市 美国经济数据分化加剧，财政主导风险升温 美国 12 月非农就业增 5 万不及预期，年度增幅创疫情后最弱，就业数据拖 累降息预期。美国 12 月非农就业人数仅增加 5 万人，低于预期的 6.5 万， 且前两个月数据合计下修 7.6 万人，导致全年新增就业仅为 58.4 万人， 创疫情以来最低水平。尽管失业率从 4.5%降至 4.4%，薪资同比增长 3.8%， 但劳动力参与率下降表明就业市场的改善并不稳固。这份疲弱的就业报 告发布后，利率互换市场对美联储 1 月降息的预期几乎完全消失，预计 首次降息将推迟至 6 月，全年降息幅度约为 50 个基点。我们认为失业 率意外下降暂时缓解了劳动力市场的担忧，支持美联储在 1 月会议保持 观望态度。 美国 12 月制造业 PMI 持续萎缩，服务业回暖。12 月美国 ISM 制造业 PMI 跌至 47.9，连续第十个月低于荣枯线 50，显示制造业持续收缩且降幅 为近年来最大。新订单和出口订单持续萎缩，尽管就业指标降幅收窄， 成本压力依旧高企。相比之下，服务业表现强劲，ISM 服务业 PMI ...

证券研究报告 | 2026年01月11日 2026年01月12日 策略周报 灵活型外资或明显参与开门红行情——1 月第 1 周全球外资周 观察 核心结论：①北向资金：最近一周可能小幅净流入，其中灵活型外资可能小 幅净流入。②港股：稳定型外资流出 216 亿港元，灵活型外资流入 365 亿港 元，港股通流入 156 亿港元。③亚太市场：外资本周流出日本，12 月外资流 出印度。④美欧市场：11 月资金流入欧洲，流入美国。 A 股：最近一周北向资金可能小幅净流入。最近一周（2026/1/5-2026/1/9， 下 同 ） 交 易 日 期 间 北 向 资 金 估 算 净 流 入 96 亿 元 ， 前 一 周 （2025/12/29-2025/12/31，下同）估算净流出 31 亿元。最近一周交易日期 间灵活型外资估算净流入 32 亿元，前一周估算净流入 17 亿元。此外，我们 汇总最近一周陆股通每日前十大活跃个股，其中宁德时代（本周陆股通双向 成交总金额为 225 亿元，占个股当周交易金额比重的 20%，下同）、中际旭 创（185 亿元、10%）、紫金矿业（156 亿元、14%）成交较为活跃。 港股：最近一周外资回 ...

上周共上报 35 只基金，较上上周申报数量有所减少。申报的产品包括 4 只 FOF，易方达中证细分有色金属产业主题 ETF、华泰柏瑞中证工业有 色金属主题 ETF 鑫元中证 800 自由现金流 ETF、广发中证有色金属矿 业主题 ETF、广发恒指港股通 ETF 等。 证券研究报告 | 2026年01月11日 2026年01月12日 基金周报 开年首只"日光基"诞生，睿远基金时隔近 6 年再发三年持有期基金 核心观点 金融工程周报 上周市场回顾。上周 A 股市场主要宽基指数全线上涨，科创 50、中证 500、 中证 1000 指数收益靠前，收益分别为 9.80%、7.92%、7.03%，沪深 300、上证综指、创业板指指数收益靠后，收益分别为 2.79%、3.82%、 3.89%。 从成交额来看，上周主要宽基指数成交额均有所上升。行业方面，上周 国防军工、传媒、有色金属收益靠前，收益分别为 14.56%、13.55%、 8.66%，银行、交通运输、石油石化收益靠后，收益分别为-1.88%、 -0.03%、0.17%。 截至上周五，央行逆回购净回笼资金 18076 亿元，逆回购到期 19463 亿元，净公开市场投 ...

证券研究报告 | 2026年01月11日 2026年01月12日 基金周报 开年首只"日光基"诞生，睿远基金时隔近 6 年再发三年持有期基金 核心观点 金融工程周报 上周市场回顾。上周 A 股市场主要宽基指数全线上涨，科创 50、中证 500、 中证 1000 指数收益靠前，收益分别为 9.80%、7.92%、7.03%，沪深 300、上证综指、创业板指指数收益靠后，收益分别为 2.79%、3.82%、 3.89%。 从成交额来看，上周主要宽基指数成交额均有所上升。行业方面，上周 国防军工、传媒、有色金属收益靠前，收益分别为 14.56%、13.55%、 8.66%，银行、交通运输、石油石化收益靠后，收益分别为-1.88%、 -0.03%、0.17%。 1 月 7 日，华泰柏瑞基金发布公告，旗下沪深 300ETF（510300）的场 内扩位简称，从"沪深 300ETF"正式更新为"沪深 300ETF 华泰柏瑞"，该 变更将于 1 月 9 日生效。 1 月 7 日，睿远基金旗下睿远研选均衡三年持有混合发起式基金发行。 这是时隔近 6 年，睿远基金再度推出三年持有期基金新品。 开放式公募基金表现。上周主动权益、灵 ...